Therapeutics and wellness products provider Jupiter Wellness (NASDAQ:JUPW) has been granted a patent for Minoxidil Adjuvant Therapies which the company acquired via its recent Applied Biology assets acquisition.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Importantly, the development boosts JUPW’s standing in the hair loss market and it can further expand its footprint in this lucrative market.
Further, JUPW has licensed the therapies under the patent to Taisho Pharmaceutical which is the biggest minoxidil marketer in Japan.
Is Jupiter Wellness Stock a Good Buy?
While JUPW has no analyst coverage yet, our data highlights investors remain very positive about JUPW stock. The total number of investor portfolios that hold Juniper Wellness stock has increased by 4.8% in the last 30 days alone.
Read full Disclosure